List of Tables
Table 1. Global Radiopharmaceutical Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Radiopharmaceutical Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Radiopharmaceutical Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Radiopharmaceutical Therapy Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Radiopharmaceutical Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Radiopharmaceutical Therapy Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Radiopharmaceutical Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Radiopharmaceutical Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Radiopharmaceutical Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Radiopharmaceutical Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Radiopharmaceutical Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceutical Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Radiopharmaceutical Therapy Sales by Region (2020-2025) & (K Dose)
Table 18. Global Radiopharmaceutical Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Radiopharmaceutical Therapy Sales by Region (2026-2031) & (K Dose)
Table 20. Global Radiopharmaceutical Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Radiopharmaceutical Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Radiopharmaceutical Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Radiopharmaceutical Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Radiopharmaceutical Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Radiopharmaceutical Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Radiopharmaceutical Therapy Sales by Country (2020-2025) & (K Dose)
Table 27. North America Radiopharmaceutical Therapy Sales by Country (2026-2031) & (K Dose)
Table 28. North America Radiopharmaceutical Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Radiopharmaceutical Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Radiopharmaceutical Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Radiopharmaceutical Therapy Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Radiopharmaceutical Therapy Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Radiopharmaceutical Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Radiopharmaceutical Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Radiopharmaceutical Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Radiopharmaceutical Therapy Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Radiopharmaceutical Therapy Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Radiopharmaceutical Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Radiopharmaceutical Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Radiopharmaceutical Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Radiopharmaceutical Therapy Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Radiopharmaceutical Therapy Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Radiopharmaceutical Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Radiopharmaceutical Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Radiopharmaceutical Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Radiopharmaceutical Therapy Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Radiopharmaceutical Therapy Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Radiopharmaceutical Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Radiopharmaceutical Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Radiopharmaceutical Therapy Sales (K Dose) by Type (2020-2025)
Table 51. Global Radiopharmaceutical Therapy Sales (K Dose) by Type (2026-2031)
Table 52. Global Radiopharmaceutical Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Radiopharmaceutical Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Radiopharmaceutical Therapy Price (US$/Dose) by Type (2020-2025)
Table 59. Global Radiopharmaceutical Therapy Price (US$/Dose) by Type (2026-2031)
Table 60. Global Radiopharmaceutical Therapy Sales (K Dose) by Application (2020-2025)
Table 61. Global Radiopharmaceutical Therapy Sales (K Dose) by Application (2026-2031)
Table 62. Global Radiopharmaceutical Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Radiopharmaceutical Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Radiopharmaceutical Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Radiopharmaceutical Therapy Price (US$/Dose) by Application (2020-2025)
Table 69. Global Radiopharmaceutical Therapy Price (US$/Dose) by Application (2026-2031)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Cardinal Health Radiopharmaceutical Therapy Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. GE Healthcare Radiopharmaceutical Therapy Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Jubilant Pharma Radiopharmaceutical Therapy Product
Table 84. Jubilant Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Novartis Radiopharmaceutical Therapy Product
Table 89. Novartis Recent Developments/Updates
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Curium Pharma Radiopharmaceutical Therapy Product
Table 94. Curium Pharma Recent Developments/Updates
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. SIEMENS Radiopharmaceutical Therapy Product
Table 99. SIEMENS Recent Developments/Updates
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Lantheus Radiopharmaceutical Therapy Product
Table 104. Lantheus Recent Developments/Updates
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Bracco Imaging Radiopharmaceutical Therapy Product
Table 109. Bracco Imaging Recent Developments/Updates
Table 110. Bayer Company Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Bayer Radiopharmaceutical Therapy Product
Table 114. Bayer Recent Developments/Updates
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Eli Lilly Radiopharmaceutical Therapy Product
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Aurobindo Pharma Company Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Radiopharmaceutical Therapy Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Mundipharma Company Information
Table 126. Mundipharma Description and Business Overview
Table 127. Mundipharma Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Mundipharma Radiopharmaceutical Therapy Product
Table 129. Mundipharma Recent Developments/Updates
Table 130. China Isotope & Radiation Company Information
Table 131. China Isotope & Radiation Description and Business Overview
Table 132. China Isotope & Radiation Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. China Isotope & Radiation Radiopharmaceutical Therapy Product
Table 134. China Isotope & Radiation Recent Developments/Updates
Table 135. Yantai Dongcheng Pharmaceutical Group Company Information
Table 136. Yantai Dongcheng Pharmaceutical Group Description and Business Overview
Table 137. Yantai Dongcheng Pharmaceutical Group Radiopharmaceutical Therapy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Yantai Dongcheng Pharmaceutical Group Radiopharmaceutical Therapy Product
Table 139. Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Radiopharmaceutical Therapy Distributors List
Table 143. Radiopharmaceutical Therapy Customers List
Table 144. Radiopharmaceutical Therapy Market Trends
Table 145. Radiopharmaceutical Therapy Market Drivers
Table 146. Radiopharmaceutical Therapy Market Challenges
Table 147. Radiopharmaceutical Therapy Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Radiopharmaceutical Therapy
Figure 2. Global Radiopharmaceutical Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiopharmaceutical Therapy Market Share by Type: 2024 & 2031
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapeutic Radiopharmaceuticals Product Picture
Figure 6. Global Radiopharmaceutical Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Radiopharmaceutical Therapy Market Share by Application: 2024 & 2031
Figure 8. Oncology
Figure 9. Cardiology
Figure 10. Other
Figure 11. Global Radiopharmaceutical Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Radiopharmaceutical Therapy Market Size (2020-2031) & (US$ Million)
Figure 13. Global Radiopharmaceutical Therapy Sales (2020-2031) & (K Dose)
Figure 14. Global Radiopharmaceutical Therapy Average Price (US$/Dose) & (2020-2031)
Figure 15. Radiopharmaceutical Therapy Report Years Considered
Figure 16. Radiopharmaceutical Therapy Sales Share by Manufacturers in 2024
Figure 17. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Radiopharmaceutical Therapy Players: Market Share by Revenue in Radiopharmaceutical Therapy in 2024
Figure 19. Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Radiopharmaceutical Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Radiopharmaceutical Therapy Sales Market Share by Country (2020-2031)
Figure 22. North America Radiopharmaceutical Therapy Revenue Market Share by Country (2020-2031)
Figure 23. United States Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Radiopharmaceutical Therapy Sales Market Share by Country (2020-2031)
Figure 26. Europe Radiopharmaceutical Therapy Revenue Market Share by Country (2020-2031)
Figure 27. Germany Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Radiopharmaceutical Therapy Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Radiopharmaceutical Therapy Revenue Market Share by Region (2020-2031)
Figure 34. China Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Radiopharmaceutical Therapy Sales Market Share by Country (2020-2031)
Figure 44. Latin America Radiopharmaceutical Therapy Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Radiopharmaceutical Therapy Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Radiopharmaceutical Therapy Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Radiopharmaceutical Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Radiopharmaceutical Therapy by Type (2020-2031)
Figure 54. Global Revenue Market Share of Radiopharmaceutical Therapy by Type (2020-2031)
Figure 55. Global Radiopharmaceutical Therapy Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Radiopharmaceutical Therapy by Application (2020-2031)
Figure 57. Global Revenue Market Share of Radiopharmaceutical Therapy by Application (2020-2031)
Figure 58. Global Radiopharmaceutical Therapy Price (US$/Dose) by Application (2020-2031)
Figure 59. Radiopharmaceutical Therapy Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
